The largest database of trusted experimental protocols

6 protocols using hitrap kappaselect

1

Isolation and Purification of Human mAbs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human mAbs were isolated previously from healthy adults who were naturally infected with a GII.4 Sydney virus in 2013 using an established human B cell hybridoma technique (27 (link)). Here, cloned hybridoma cell lines that had been cryopreserved were thawed and placed into culture and expanded gradually from 48-well plates to 12-well plates, T-25, T-75, and eventually to multiple T-225 flasks for each cell line. Following 4 weeks of incubation at 37°C, supernatant from the T-225 flasks was harvested and filtered through a 0.4-µm filter. The supernatant was purified using column chromatography, specifically HiTrap KappaSelect and Lambda FabSelect affinity resins (GE Healthcare Life Sciences).
+ Open protocol
+ Expand
2

Purification and Characterization of IgA1

Check if the same lab product or an alternative is used in the 5 most similar protocols
IgA1 was purified from the supernatant of cell culture with HiTrap KappaSelect (GE Healthcare, USA). The purified samples were analysed in gel-electrophoresis by 4–11 % SDS-PAGE under reducing and non-reducing conditions. The concentration of purified IgA1 was measured by Implen NanoPhotometer™ (Implen GmbH, Germany). Purified samples were dialysed in MQ-H2O (MQ Millipore, USA) and concentrated by Pierce Protein Concentrator, PES, 30 K MWCO (Thermo Sci., USA). Concentrated samples of mAbs were lyophilized using vacuum freeze dryer VirTis (Labconco, USA) and used for further glycan analyses.
+ Open protocol
+ Expand
3

Purification and Characterization of Chimeric Anti-BLG Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Supernatants from transiently transfected CHO cells were collected, and then cleared by centrifugation at 3500 g for 10 minutes at RT. Chimeric anti-BLG antibodies were purified using either HiTrap KappaSelect (chimeric human IgE antibodies) or HiTrap protein A HP (chimeric human IgG1 antibodies) columns (GE Healthcare) on an ÄKTAprime plus liquid chromatography system (GE Healthcare). Briefly, culture supernatants were adjusted to pH 7.2 and loaded onto affinity columns. After washing with PBS pH 7.2, chimeric anti-BLG antibodies were eluted from affinity columns with 0.1 M glycine buffer pH 3.0, and instantly neutralized in 1 M Tris buffer pH 9.0. After dialysis against PBS pH 7.2, antibody concentrations were determined by measuring the absorbance at 280 nm. Extinction coefficients (1 mg/ml at 1 cm pathway) of 1.53 and 1.36 [22] were used for chimeric IgE antibodies and chimeric IgG1 antibodies, respectively. Purity of chimeric anti-BLG antibodies was analyzed with SDS-PAGE using a pre-casted 4–12% BisTris gel/MOPS running buffer NuPage Novex system (Invitrogen) followed by Coomassie Brilliant Blue staining (BioRad). MW Magic ladder (BioRad) was run in parallel to estimate the molecular weight of proteins.
+ Open protocol
+ Expand
4

Producing Monoclonal Antibodies Against NORO-320

Check if the same lab product or an alternative is used in the 5 most similar protocols
After cloning, hybridoma cell lines producing cross-reactive mAbs were expanded gradually from 48-well plates to 12-well plates, T-25, T-75 and eventually to four T-225 flasks for each cell line. Supernatant from each cell line also was screened by ELISA to determine the corresponding light chain for each clone. Following 4 weeks of incubation at 37 °C, supernatant from the four T-225 flasks was harvested and filtered through a 0.4-µm filter. The supernatant was filtered using column chromatography, specifically HiTrap KappaSelect and Lambda FabSelect affinity resins (GE Healthcare Life Sciences). To obtain varying forms of NORO-320, we expressed the heavy and kappa light chain variable domains using Fab or IgG protein recombinant expression vectors. cDNAs encoding the corresponding heavy and light chains were transfected using ExpiCHOTM (Chinese hamster ovary) cells (Thermo Fisher Scientific).
+ Open protocol
+ Expand
5

Hybridoma Cloning and Antibody Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wells containing reactive hybridomas were cloned by single-cell fluorescence-activated cell sorting. These hybridoma clones were expanded in Medium E serially into 48-well plates, 12-well plates, and T-75 cm2 flasks, respectively. Hybridoma clones were expanded further into T-225 cm2 flasks or G-Rex® devices (Wilson Wolf) in serum-free medium (Hybridoma SFM [Gibco]). Supernatants were harvested after approximately 21 days, or in sets of 3 to 5 days, respectively, through a 0.2-μm pore size filter. Antibodies were purified from the filtrate using HiTrap Protein G (GE Healthcare Life Sciences), HiTrap MabSelect SuRe (GE Healthcare Life Sciences), HiTrap KappaSelect (GE Healthcare Life Sciences), HiTrap LambdaFabSelect (GE Healthcare Life Sciences), or CaptureSelect IgA affinity matrix (Thermo Fisher Scientific) columns on an ÄKTA pure 25M chromatography system. Antibodies were concentrated using 50K MWCO Amicon® Ultra centrifugal filter units (Millipore) followed by desalting and buffer exchange with 7K MWCO Zeba desalting columns (Thermo Fisher Scientific).
+ Open protocol
+ Expand
6

Generation and Purification of NKG2D Bispecific Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The NKG2D-CD16 and NKG2D-CD3 constructs were generated as described previously (21 (link)). In brief, the constructs were produced in SP2/0-Ag14 cells (American Type Culture Collection, Manassas, VA) and purified from culture supernatant by HiTrap KappaSelect affinity chromatography (GE Healthcare, Munich, Germany) followed by preparative size exclusion chromatography on Superdex HiLoad. Analytical size exclusion chromatography (Superdex 200R PC3.2/30, GE Healthcare) and 4-12% gradient SDS-PAGE (Invitrogen, Carlsbad, CA) was performed to confirm the quality and exclude aggregation of purified bispecific fusion proteins. Endotoxin levels were measured with EndoZyme II (BioMerieux, Marcy-l’Étoile, France) according to the manufacturer’s instructions and below endotoxin levels EU=0.1.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!